Singapore markets closed
Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,433.95 +173.21 (+0.27%) CMC Crypto 200
1,353.46 -6.86 (-0.50%)
PreveCeutical Medical Inc. (18H.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:02AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 9.21M |
| Enterprise value | 11.79M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 2.74k |
| Enterprise value/EBITDA | -7.95 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | -37.50% |
| S&P500 52-week change 3 | 26.24% |
| 52-week high 3 | 0.0275 |
| 52-week low 3 | 0.0100 |
| 50-day moving average 3 | 0.0119 |
| 200-day moving average 3 | 0.0140 |
Share statistics
| Avg vol (3-month) 3 | 2.92k |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 539.9M |
| Implied shares outstanding 6 | 921.24M |
| Float 8 | 468.87M |
| % held by insiders 1 | 24.09% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 5:1 |
| Last split date 3 | 23 May 2018 |
Financial highlights
Currency in CAD.Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -286.27% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -816.32k |
| Net income avi to common (ttm) | -517.52k |
| Diluted EPS (ttm) | -0.0000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.68k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 3.78M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.02 |
| Book value per share (mrq) | -0.01 |
Cash flow statement
| Operating cash flow (ttm) | -31.59k |
| Levered free cash flow (ttm) | 75.87k |
© 2024 Yahoo. All rights reserved.